Muzaffer Sanci | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Muzaffer Sanci — İzmir Şehir Hastanesi, Turkey

Muzaffer Sanci
Affiliation İzmir Şehir Hastanesi
Country Turkey
Scopus ID 6508123738
Documents 165
Citations 1,526
h-index 21
Subject Area Epidemiology
Event Global Diseases Research Awards

Muzaffer Sanci is a researcher affiliated with İzmir Şehir Hastanesi in Turkey whose documented scholarly profile is associated with epidemiology. The recognition presented here concerns the Innovative Research Award within the Global Diseases Research Awards, emphasizing research activity, publication output, citation visibility, and potential relevance to contemporary disease research.[1]

Abstract

Muzaffer Sanci’s academic profile indicates sustained research activity in epidemiology, supported by 165 indexed documents, 1,526 citations, and an h-index of 21. His affiliation with İzmir Şehir Hastanesi, Turkey, places the profile within a clinical and public-health environment relevant to disease investigation. The Innovative Research Award recognizes research-oriented contributions where methodological development, evidence generation, and practical relevance may support advances in health science. The available bibliometric indicators provide a quantitative description of scholarly visibility, while interpretation of individual contributions should consider publication quality, authorship roles, research methods, and relevance to global disease challenges and population health priorities.[1]

Keywords

Muzaffer Sanci; epidemiology; innovative research; disease research; clinical research; bibliometrics; Scopus; Global Diseases Research Awards; Turkey.[1]

Introduction

Epidemiology examines the distribution, determinants, and control of health-related conditions across populations. Its methods support disease surveillance, risk assessment, prevention, and evaluation of interventions. Researchers working in clinical and population-health settings can contribute evidence that connects observed health patterns with diagnostic, therapeutic, and public-health decision-making and policy development.[2]

Research Profile

The supplied Scopus information records 165 documents, 1,526 citations, and an h-index of 21 for Muzaffer Sanci. These indicators describe indexed publication activity and citation impact, but they do not independently establish research quality. Bibliometric measures should therefore be interpreted alongside study design, originality, collaboration, and substantive contribution to knowledge and practice.[1]

Research Contributions

An epidemiology-focused research profile may encompass investigation of disease patterns, risk factors, clinical outcomes, prevention strategies, and population-level evidence. For award assessment, relevant contributions can be examined through documented publications, methodological approaches, datasets, collaborations, and the extent to which findings address clearly defined scientific or healthcare problems in practice.[2]

Publications

The supplied profile identifies 165 Scopus-indexed documents but does not provide a complete publication list or individual article metadata. Consequently, this article does not attribute specific findings to particular papers without verification. Publication assessment should use the author’s indexed record, including titles, journals, citation counts, authorship position, and persistent identifiers.[1]

Research Impact

A citation count of 1,526 and an h-index of 21 indicate measurable scholarly visibility within the supplied Scopus record. Such indicators can help contextualize research influence, while citation practices vary among disciplines. A balanced assessment should also consider clinical relevance, reproducibility, methodological rigor, collaboration, and evidence of use beyond citation counts.[1][3]

Award Suitability

The Innovative Research Award is potentially aligned with an epidemiology researcher when documented work demonstrates originality, methodological advancement, meaningful evidence generation, or practical relevance. Muzaffer Sanci’s supplied publication and citation indicators provide contextual evidence of research activity, while final award suitability should depend on independently verified scholarly contributions and eligibility criteria for recognition.[5]

Conclusion

Muzaffer Sanci’s supplied academic record presents an established epidemiology-oriented research profile, with 165 documents, 1,526 citations, and an h-index of 21. These metrics support recognition of sustained scholarly activity, but they should be considered with qualitative evidence. The Innovative Research Award assessment should therefore combine bibliometric information with verified research contributions and documented scientific relevance.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Muzaffer Sanci, Author ID 6508123738. Scopus.
    https://www.scopus.com/pages/authors/6508123738
  2. Özuyar Şimşek, G., Uzunlar, Ö., Özen, S., Çandar, T., Sancı, M., & Duman, E. D. (2026). Investigation of the effect of TNF-α levels on infertility duration and infertility characteristics in endometriosis patients presenting with infertility complaints. BMC Women’s Health, 26(1).
    https://doi.org/10.1186/s12905-026-04586-w
  3. Özen, S., Güner Özen, E., Özuyar Şimşek, G., Arzik, A. O., Karaoğlu, S., Akdemir, C., & Sanci, M. (2026). HPV persistence and CIN2+ detection in women with normal cytology and non-16/18 high-risk HPV positivity. BMC Women’s Health.
    https://doi.org/10.1186/s12905-026-04278-5
  4. Korkmaz, O., Aydemir, I., Turkoz Uluer, E., Sancı, M., Diniz, G., Sayhan, S., & İnan, S. (2026). Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: Evidence from cell lines and human tissues. Journal of Molecular Histology, 57, Article 262.
    https://doi.org/10.1007/s10735-026-10930-z
  5. Özen, S., Güner Özen, E., & Sancı, M. (2026). Preoperative imaging for nodal assessment in endometrial carcinoma: A comparative study of MRI and 18F-FDG PET/CT across risk groups. Medicina, 62(7), 1418.
    https://doi.org/10.3390/medicina62071418

 

Werner Mohl | Epidemiology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Werner Mohl
Medical University of Vienna
Werner Mohl
Affiliation Medical University of Vienna
Country Austria
Scopus ID 21641111500
Documents 113
Citations 1,315
h-index 20
Subject Area Epidemiology
Event Global Diseases Research Awards
ORCID 0000-0002-4894-0494

Werner Mohl is a researcher affiliated with the Medical University of Vienna whose scholarly activities have contributed to biomedical and epidemiological investigations through a sustained publication record. His academic profile demonstrates measurable scientific influence through peer-reviewed outputs, citation performance, and interdisciplinary engagement. The present article evaluates his research profile in the context of the Innovative Research Award associated with the Global Diseases Research Awards program.[1]

Abstract

This article presents an academic overview of Werner Mohl and evaluates the scholarly characteristics supporting consideration for the Innovative Research Award. Affiliated with the Medical University of Vienna, Mohl has established a publication portfolio comprising 113 indexed documents and 1,315 citations with an h-index of 20. His research activities demonstrate continued engagement in biomedical and epidemiological investigations while contributing to scientific literature through collaborative and peer-reviewed scholarship. Bibliometric indicators suggest sustained research productivity and measurable academic visibility. These achievements collectively provide a foundation for assessing scientific influence, knowledge dissemination, and potential recognition within international research award frameworks.[1]

Keywords

Werner Mohl; Medical University of Vienna; Epidemiology; Biomedical Research; Scientific Publications; Citation Analysis; Research Impact; Academic Recognition; Global Diseases Research Awards; Innovative Research Award.

Introduction

Recognition through scientific awards generally reflects the quality, consistency, and influence of a researcher’s contributions within a specific field. Werner Mohl’s academic profile indicates sustained participation in scientific research, publication activity, and scholarly communication. Such characteristics provide an important basis for evaluating his professional achievements within the context of international academic recognition programs and competitive award assessments.[4]

Research Profile

According to available bibliometric indicators, Werner Mohl has authored or co-authored 113 scholarly documents indexed in Scopus. These publications have accumulated 1,315 citations, resulting in an h-index of 20. Such metrics indicate a research portfolio characterized by sustained productivity and citation visibility, suggesting that a substantial number of publications have contributed to ongoing academic discourse and scientific advancement.[3]

Research Contributions

Mohl’s research contributions are associated with biomedical and epidemiological investigations that support evidence generation and scientific understanding within health-related disciplines. His scholarly work demonstrates engagement with topics relevant to disease mechanisms, clinical outcomes, and translational applications. Through collaborative publications and peer-reviewed dissemination, his research has contributed to the broader body of scientific knowledge available to researchers and healthcare professionals.[2]

Publications

The publication record associated with Werner Mohl reflects long-term engagement in scientific communication through peer-reviewed articles and collaborative research outputs. Publication activity serves as an indicator of knowledge dissemination and scholarly participation. The breadth of documented research contributions demonstrates ongoing involvement in advancing scientific understanding while supporting the exchange of evidence-based findings within the international academic community.[5]

Research Impact

Research impact may be assessed through citation performance, publication visibility, and scholarly influence. With 1,315 citations and an h-index of 20, Mohl’s academic profile demonstrates measurable engagement from the scientific community. These indicators suggest that multiple publications have been referenced by subsequent studies, reflecting continued relevance and contribution to ongoing scientific discussions and evidence development.[1]

Award Suitability

Assessment for the Innovative Research Award may consider factors including publication productivity, citation influence, research quality, and contribution to scientific advancement. Werner Mohl’s documented scholarly record demonstrates characteristics commonly associated with academic recognition. His bibliometric performance, institutional affiliation, and continued contribution to research activities collectively support consideration for distinction within the Global Diseases Research Awards framework.[1]

Conclusion

Werner Mohl’s academic profile reflects sustained scholarly productivity, measurable citation impact, and continued participation in biomedical and epidemiological research. Available indicators suggest a well-established research presence supported by peer-reviewed publications and scientific engagement. Based on the documented evidence, his professional achievements align with criteria frequently considered in international research award evaluations and academic recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Werner Mohl, Author ID 21641111500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21641111500
  2. Global Diseases Research Awards. (n.d.). Award information and recognition framework.
    https://globaldiseases.org/
  3. Mohl, W., Spitzer, E., Mader, R. M., Wagh, V., Nguemo, F., Milasinovic, D., Jusić, A., Khazen, C., Szodorai, E., Birkenberg, B., Lubec, G., Hescheler, J., & Serruys, P. W. (2018). Acute molecular effects of pressure-controlled intermittent coronary sinus occlusion in patients with advanced heart failure. ESC Heart Failure, 5(5), 878–886.
    https://doi.org/10.1002/ehf2.12354
  4. Wagh, V., Nguemo, F., Kiseleva, Z., Mader, R. M., Hescheler, J., & Mohl, W. (2023). Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10-year survival. ESC Heart Failure, 10(6), 3921–3932. https://doi.org/10.1002/ehf2.14516
  5. Mohl, W., Kiseleva, Z., Jusić, A., Bruckner, M., & Mader, R. M. (2023). Signs and signals limiting myocardial damage using PICSO: A scoping review decoding paradigm shifts toward a new encounter. Frontiers in Cardiovascular Medicine, 10, 1030842. https://doi.org/10.3389/fcvm.2023.1030842

Alaa Hamza Abbas | Epidemiology | Best Researcher Award

Published on by Global Diseases Research

Dr. Alaa Hamza Abbas | Epidemiology | Best Researcher Award 

Lecturer | Al-Mustaqbal University | Iraq

Dr. Alaa Hamza Abbas Sultan is a distinguished academic and researcher from Iraq, currently serving as Director of the Drugs and Forensic Poisons Information Center at Diwaniyah Health. He earned his Ph.D. and M.Sc. in Pharmacology from Al-Nahrain University, following a Bachelor of Pharmacy from Mosul University. His professional journey includes roles as a pharmacist, lecturer, certified trainer, and health administrator, contributing significantly to clinical pharmacology, medical education, and healthcare development. Dr. Abbas has been actively involved in reviewing for reputable journals and has participated in numerous international conferences, both as a researcher and reviewer. His research focuses on pharmacological interventions for metabolic disorders, inflammation, and dermatological conditions, with several impactful studies exploring the therapeutic effects of natural products and pharmacological agents, especially in models of hyperglycemia, hyperlipidemia, and psoriasis. Notable publications include articles in Naunyn-Schmiedeberg’s Archives of Pharmacology, ACS Pharmacology & Translational Science, and the Journal of Taibah University Medical Sciences. Beyond research, he contributes to teaching pharmacology, histology, and medical sciences, mentoring future professionals. His scholarly presence is recognized across Google Scholar, Scopus, ORCID, and Web of Science, reflecting his integration into the global scientific community. Dr. Abbas has authored 10 publications, which collectively received 165 citations from 48 documents, showcasing the relevance of his work. His contributions have earned him an h-index of 8, reflecting both productivity and citation impact in his field

Profiles:  Scopus |  Google Scholar | ORCID

Featured Publications

1. Salman, H. R., Alzubaidy, A. A., Abbas, A. H., & Mohammad, H. A. (2024). Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. Journal of Taibah University Medical Sciences, 19(1), 35–53. Cited by: 30

2. Hayder Ridha-Salman, D. M. H. S. A. M., Al-Zubaidy, A. A., & Abbas, A. H. (2024). The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation. Naunyn-Schmiedeberg’s Archives of Pharmacology, 398, 1–21. Cited by: 29*

3. Ridha-Salman, H., Shihab, E. M., Hasan, H. K., Abbas, A. H., Khorsheed, S. M., & others. (2024). Mitigative effects of topical norfloxacin on an imiquimod-induced murine model of psoriasis. ACS Pharmacology & Translational Science, 7(9), 2739–2754. Cited by: 29

4. Hayder Ridha-Salman, A. H. A. Q. A. Z., & Al-Zubaidy, A. A. (2023). The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice. Naunyn-Schmiedeberg’s Archives of Pharmacology. Cited by: 28*

5. Abbas, A. H. (2023). The attenuated effects of Epagliflozin on imiquimod-induced model of psoriasis. Latin American Journal of Pharmacy, 42(Special Issue), 362–369. Cited by: 21